Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 19:37 PM 2012  
PTTDX PTTCX PTRAX PTTAX PTRRX PTTPX 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for SLXP and PXRAX ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Salix Pharmaceuticals Ltd.  and   Virtus Intl Real Estate Securi
Check Correlation Matrix  
Daily Returns (%)
SLXP  PXRAX  
Timeline
Given investment horizon of 30 days, Salix Pharmaceuticals Ltd. is expected to generate 2.88 times more return on investment than Virtus. However, Salix is 2.88 times more volatile than Virtus Intl Real Estate Securities A. It trades about 0.07 of its potential returns per unit of risk. Virtus Intl Real Estate Securities A is currently generating about -0.36 per unit of risk. If you would invest 5,055 in Salix Pharmaceuticals Ltd. on April 26, 2012 and sell it today you would earn a total of 32.00 from holding Salix Pharmaceuticals Ltd. or generate 0.63% return on investment over 30 days.

Diversification

Poor diversification
Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Virtus Intl Real Estate Securi in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.65
 Parameters
Time Period1 Month [change]
DirectionPositive PXRAX Moved Up vs SLXP
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between SLXP and PXRAX with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between SLXP and PXRAX to your reader
 
Get social with Correlation between SLXP and PXRAX
 Share Correlation between SLXP and PXRAX 
Share Share Correlation between SLXP and PXRAX
    
    
 
       
Predicted Return Density
Expected Daily Returns   
SLXP  PXRAX  

Salix Pharmaceuticals Ltd.

 
    
    
Salix
Performance
3
Out Of
100
Over 30
Days
97% of all equities and portfolios perform better than Salix Pharmaceuticals Ltd.. Compared with the overall equity markets, risk-adjusted returns on investments in Salix Pharmaceuticals Ltd. are ranked lower than 3 (%) of all global equities and portfolios over the last 30 days.
    
    
Mylan Inc. vs. Salix Pharmaceuticals Ltd.
Watson Pharmaceuticals Inc. vs. Salix Pharmaceuticals Ltd.
Medicis Pharmaceutical Corporation vs. Salix Pharmaceuticals Ltd.
Par Pharmaceutical Companies Inc. vs. Salix Pharmaceuticals Ltd.
Akorn Inc. vs. Salix Pharmaceuticals Ltd.
Hi Tech Pharmacal Inc. vs. Salix Pharmaceuticals Ltd.
  

Virtus Intl Real Estate Securities A

 
    
    
Virtus
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Virtus Intl Real Estate Securities A has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
ING GLOBAL REAL ESTATE FD CL R vs. Virtus Intl Real Estate Securities A
ING Global Real Estate C vs. Virtus Intl Real Estate Securities A
ING Global Real Estate A vs. Virtus Intl Real Estate Securities A
ING Global Real Estate I vs. Virtus Intl Real Estate Securities A
ING Global Real Estate B vs. Virtus Intl Real Estate Securities A
ING Global Real Estate O vs. Virtus Intl Real Estate Securities A
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting